Indication
Allergic bronchopulmonary aspergillosis
Allergic bronchopulmonary aspergillosis is a complex immunological pulmonary disorder characterized by a hypersensitivity response to colonization of the lower airways by *Aspergillus* species, primarily *Aspergillus fumigatus*. Read more about Allergic bronchopulmonary aspergillosis
99 drugs 74 manufacturers
Drugs that treat it
Common Allergic bronchopulmonary aspergillosis therapies.
PREDNISONE
PREDNISONE
PREDNISOLONE
PREDNISONE
PREDNISONE
PREDNISOLONE SODIUM PHOSPHATE
PREDNISOLONE SODIUM PHOSPHATE
PREDNISOLONE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAllergic bronchopulmonary aspergillosis is a complex immunological pulmonary disorder characterized by a hypersensitivity response to colonization of the lower airways by *Aspergillus* species, primarily *Aspergillus fumigatus*.
It predominantly affects individuals with underlying chronic respiratory conditions, specifically asthma and cystic fibrosis.
Pathophysiologically driven by an exaggerated T-helper type 2 inflammatory reaction, the condition is clinically marked by recurrent wheezing, cough with brown mucus plugs, pulmonary infiltrates, peripheral blood and sputum eosinophilia, and elevated total and fungus-specific serum immunoglobulin E levels.
Without timely recognition, persistent airway inflammation can cause central bronchiectasis and irreversible fibrotic lung damage.
- nih.gov
Allergic bronchopulmonary aspergillosis is a complex immunological pulmonary disorder characterized by a hypersensitivity response to colonization of the lower airways by *Aspergillus* species, primarily *Aspergillus fumigatus* It predominantly affects individuals with underlying chronic respiratory conditions, specifically asthma and cystic fibrosis
- nih.gov
Allergic bronchopulmonary aspergillosis is a complex immunological pulmonary disorder characterized by a hypersensitivity response to colonization of the lower airways by *Aspergillus* species, primarily *Aspergillus fumigatus*
- nih.gov
It predominantly affects individuals with underlying chronic respiratory conditions, specifically asthma and cystic fibrosis Pathophysiologically driven by an exaggerated T-helper type 2 inflammatory reaction, the condition is clinically marked by recurrent wheezing, cough with brown mucus plugs, pulmonary infiltrates, peripheral blood and sputum eosinophilia, and elevated total and fungus-specific serum immunoglobulin E levels
- nih.gov
Pathophysiologically driven by an exaggerated T-helper type 2 inflammatory reaction, the condition is clinically marked by recurrent wheezing, cough with brown mucus plugs, pulmonary infiltrates, peripheral blood and sputum eosinophilia, and elevated total and fungus-specific serum immunoglobulin E levels Without timely recognition, persistent airway inflammation can cause central bronchiectasis and irreversible fibrotic lung damage
Personalize your experience
Follow Allergic bronchopulmonary aspergillosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.